Alector, Inc.

  • Market Cap: Micro Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: US0144421072
USD
2.17
0.11 (5.34%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

Comparison

Company
Score
Quality
Valuation
Financial
Technical
Editas Medicine, Inc.
Alpine Immune Sciences, Inc.
Wave Life Sciences Ltd.
Curis, Inc.
Alector, Inc.
Avid Bioservices, Inc.
Vera Therapeutics, Inc.
Enliven Therapeutics, Inc.
Allogene Therapeutics, Inc.
Anavex Life Sciences Corp.
Cabaletta Bio, Inc.

Why is Alector, Inc. ?

1
  • ROCE(HY) Lowest at -121.98%
  • RAW MATERIAL COST(Y) Grown by 67.58% (YoY)
  • CASH AND EQV(HY) Lowest at USD 598.39 MM
2
Risky -
  • The stock is trading risky as compared to its average historical valuations
  • Over the past year, while the stock has generated a return of 51.82%, its profits have risen by 34.8%
stock-recommendationReal-Time Research Report

Verdict Report

How much should you sell?

  1. All quantity irrespective of whether you are making profits or losses

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to re-enter? - We will constantly monitor the company and review our call based on new data

Is Alector, Inc. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Alector, Inc.
58.39%
-0.51
104.68%
S&P 500
13.68%
0.71
19.28%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors

Factor
Value
Sales Growth (5y)
25.42%
EBIT Growth (5y)
5.67%
EBIT to Interest (avg)
-133.50
Debt to EBITDA (avg)
Negative Net Debt
Net Debt to Equity (avg)
-3.55
Sales to Capital Employed (avg)
0.64
Tax Ratio
0.10%
Dividend Payout Ratio
0
Pledged Shares
0
Institutional Holding
100.00%
ROCE (avg)
0
ROE (avg)
0
stock-recommendationValuation

Valuation Scorecard stock-summary

stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary

Factor
Value
P/E Ratio
NA (Loss Making)
Industry P/E
Price to Book Value
4.23
EV to EBIT
0.24
EV to EBITDA
0.26
EV to Capital Employed
0.13
EV to Sales
-0.41
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
55.53%
ROE (Latest)
-179.05%
stock-recommendationTechnicals

Technical key factors

Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Bearish
Moving Averages
Bullish (Daily)
KST
Bullish
Mildly Bullish
Dow Theory
No Trend
Mildly Bullish
OBV
No Trend
Mildly Bearish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
stock-recommendationFinancial Trend

Financial Trend Scorecard stock-summary

stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

4What is working for the Company
NET PROFIT(HY)

Higher at USD -65.29 MM

DEBT-EQUITY RATIO (HY)

Lowest at -438.79 %

-18What is not working for the Company
ROCE(HY)

Lowest at -121.98%

RAW MATERIAL COST(Y)

Grown by 67.58% (YoY

CASH AND EQV(HY)

Lowest at USD 598.39 MM

NET SALES(Q)

Lowest at USD 3.26 MM

PRE-TAX PROFIT(Q)

At USD -34.77 MM has Fallen at -25.59%

NET PROFIT(Q)

At USD -34.77 MM has Fallen at -25.53%

Here's what is working for Alector, Inc.

Debt-Equity Ratio
Lowest at -438.79 %
in the last five Semi-Annual periods
MOJO Watch
The company has been reducing its borrowing as compared to equity capital

Debt-Equity Ratio

Here's what is not working for Alector, Inc.

Net Sales
At USD 3.26 MM has Fallen at -83.93%
over average net sales of the previous four periods of USD 20.28 MM
MOJO Watch
Near term sales trend is extremely negative

Net Sales (USD MM)

Net Sales
Lowest at USD 3.26 MM
in the last five periods
MOJO Watch
Near term sales trend is negative

Net Sales (USD MM)

Pre-Tax Profit
At USD -34.77 MM has Fallen at -25.59%
over average net sales of the previous four periods of USD -27.68 MM
MOJO Watch
Near term Pre-Tax Profit trend is negative

Pre-Tax Profit (USD MM)

Net Profit
At USD -34.77 MM has Fallen at -25.53%
over average net sales of the previous four periods of USD -27.7 MM
MOJO Watch
Near term Net Profit trend is negative

Net Profit (USD MM)

Cash and Eqv
Lowest at USD 598.39 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 67.58% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales